Color Hereditary Cancer Test

The OCRA Free Genetic Testing Program is a sponsored program that provides hereditary cancer testing at no cost to eligible individuals who may be at increased risk for ovarian or gynecologic cancers. It is generously funded by AstraZeneca and performed by Color Health. In addition to ovarian cancer, the test evaluates inherited risks for breast, uterine/endometrial, colorectal, and prostate cancers.

Yes, the OCRA genetic testing program is completely free to eligible participants. AstraZeneca sponsors the program and covers the full cost of testing, so there is no charge, no copay, and no bill sent to you or your insurance. You pay $0 for the test and the genetic counseling that comes with it.

The OCRA program uses an at-home saliva collection kit, so there is no blood draw required. Once you are approved, the kit is mailed to your home. You simply provide a saliva sample and send it back using the materials provided, and Color Health processes it in their laboratory.

Yes. When your results are ready, you will have access to certified genetic counselors through the OCRA program at no additional cost. These counselors can walk you through what your results mean, answer your questions, and help you and your doctor plan any next steps for your care or cancer risk management.

Yes, men can benefit from the OCRA Free Genetic Testing Program. Hereditary gene changes linked to ovarian and gynecologic cancers can also increase the risk for other cancers, including prostate and colorectal cancer, which affect men. Men who meet the program's eligibility criteria may be able to participate and learn about inherited cancer risks in their family.

No. While the OCRA program is focused on individuals at increased risk for ovarian and gynecologic cancers, the testing also evaluates inherited risks for breast cancer, uterine/endometrial cancer, colorectal cancer, and prostate cancer. This broader look at hereditary cancer syndromes can provide important information for you and your family members.

Patients may qualify for Ovarian Cancer if they meet the program's eligibility criteria:

• Individuals who may be at increased risk for ovarian or gynecologic cancer.
• Those with a family history of ovarian, breast, uterine/endometrial, colorectal, or prostate cancer.
• Individuals already diagnosed with ovarian or gynecologic cancer who have not had recent genetic testing.
• People with a known BRCA mutation in the family or Ashkenazi Jewish ancestry.
• Anyone meeting program-defined risk factors who completes the online application and is approved for testing.